Search

Your search keyword '"Pugh, Trevor J."' showing total 1,106 results

Search Constraints

Start Over You searched for: Author "Pugh, Trevor J." Remove constraint Author: "Pugh, Trevor J."
1,106 results on '"Pugh, Trevor J."'

Search Results

1. Evaluation of methods to assign cell type labels to cell clusters from single-cell RNA-sequencing data

2. “I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening

4. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours

5. Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma

6. Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer

7. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities

8. Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data

9. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

11. A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer

12. Genome screening, reporting, and genetic counseling for healthy populations

14. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment

16. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials

17. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

18. Failure of human rhombic lip differentiation underlies medulloblastoma formation

19. Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.

20. Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy

21. Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors

25. Author Correction: Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

27. Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial

28. Evaluation of methods to assign cell type labels to cell clusters from single-cell RNA-sequencing data.

30. Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab.

31. Prediction of acute myeloid leukaemia risk in healthy individuals.

32. Coenzyme A fuels T cell anti-tumor immunity

33. Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)

34. Supplementary Figures S1-S5 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium

35. Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium

36. Figure S3 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA

37. Abstract B001: Identification of monoallelic ATM loss-of-function and homologous recombination deficiency (HRD) in high-grade ovarian tumor with prolonged response to camonsertib and low-dose gemcitabine combination therapy

39. Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

40. A distinct innate lymphoid cell population regulates tumor-associated T cells

42. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers

43. Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity

44. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis

45. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene

47. Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

48. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

50. PRMT5 inhibition disrupts splicing and stemness in glioblastoma

Catalog

Books, media, physical & digital resources